Poly Medicure (531768) Investor presentation summary

Platform overview and global reach

• Operates in 125+ countries with 15 manufacturing plants across 5 countries and a 1.8 billion+ annual device capacity.

• Holds 390+ patents and has 950+ distributors and 570+ sales associates globally.

• Largest exporter of consumable medical devices for 10 consecutive years.

Innovation, R&D, and product pipeline

• 100+ R&D professionals and 30+ new product launches annually, with 100+ products in the development pipeline.

• 390+ patents granted, with strong in-house tooling, automation, and rapid prototyping capabilities.

• Plans to double R&D spending in the coming years.

Strategic acquisitions and portfolio expansion

• Acquired Plan Health, Pendracare, and Citieffe, expanding into cardiology and orthopaedics.

• Post-acquisition, Plan Health grew at 20% CAGR with improved margins; Citieffe and Pendracare added significant revenue and EBITDA.

• Focused on expanding trauma, cardiology, and orthopaedics portfolios, including new launches and clinical trials.